Time To Add-On Medication Use for Patients with Type 2 Diabetes Mellitus (T2DM) Who Failed Metformin Monotherapy

被引：0
|
作者：
Qiu, Ying
Fu, Alex Z.
Radican, Larry
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A70 / +
页数：2
相关论文
共 50 条
  • [41] Benefits beyond glycemia of adding rosiglitazone rather than glyburide to metformin monotherapy in type 2 diabetes mellitus (T2DM)
    Rood, JA
    Ryan, CM
    Cobitz, AR
    Waterhouse, BR
    Strachan, MWJ
    DIABETES, 2004, 53 : A480 - A480
  • [42] Impact of baseline gastric emptying on effects of lixisenatide and liraglutide in type 2 diabetes mellitus (T2DM) as add-on to insulin glargine
    Menge, B. A.
    Kapitza, C.
    Hincelin-Mery, A.
    Roy-Duval, C.
    Delfolie, A.
    Coester, H. -V.
    Forst, T.
    Meier, J. J.
    DIABETOLOGIA, 2014, 57 : S38 - S38
  • [43] Empagliflozin as Add-on Therapy to Pioglitazone With or Without Metformin in Patients With Type 2 Diabetes Mellitus
    Kovacs, Christopher S.
    Seshiah, Veeraswamy
    Merker, Ludwig
    Christiansen, Anita Vedel
    Roux, Flavien
    Salsali, Afshin
    Kim, Gabriel
    Stella, Peter
    Woerle, Hans-Juergen
    Broedl, Uli C.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : 1773 - 1788
  • [44] Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes Mellitus
    Masato Odawara
    Izumi Hamada
    Manabu Suzuki
    Diabetes Therapy, 2014, 5 : 169 - 181
  • [45] Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes Mellitus
    Odawara, Masato
    Hamada, Izumi
    Suzuki, Manabu
    DIABETES THERAPY, 2014, 5 (01) : 169 - 181
  • [46] Empagliflozin as Add-on to Linagliptin and Metformin in Patients with Type 2 Diabetes (T2DM): Subgroup Analysis by Baseline Demographics in a 24-Week Randomized Trial
    Seufert, Jochen
    Naderali, Ebrahim
    Maldonaldo, Mario
    Del Parigi, Angelo
    Toorawa, Robert
    Lee, Christopher
    DIABETES, 2016, 65 : A292 - A292
  • [47] Effects on lipid metabolism of metformin and troglitazone, alone and in combination, in patients with type 2 diabetes mellitus (T2DM)
    Lee, I
    Maggs, DG
    Katz, D
    Spollett, GR
    Page, SL
    Rife, FS
    Inzucchi, SE
    DIABETES, 2002, 51 : A105 - A105
  • [48] COST-EFFECTIVENESS OF ADD-ON THERAPIES TO METFORMIN: THE IMPACT OF MEDICATION ADHERENCE FOR TYPE 2 DIABETES MELLITUS
    Ho, C. M.
    Yeh, T. H.
    Lai, Y. T.
    VALUE IN HEALTH, 2021, 24 : S80 - S80
  • [49] Effectiveness of vildagliptin as add-on to metformin monotherapy among uncontrolled type 2 diabetes mellitus patients in a real-world setting
    Melzer Cohen, Cheli
    Davis, Carla
    Shalev, Varda
    Chodick, Gabriel
    JOURNAL OF DIABETES, 2018, 10 (01) : 68 - 72
  • [50] Add-on therapies to metformin for type 2 diabetes
    Shomali, Mansur
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (01) : 47 - 62
12345